Skip to main content

Aquestive Therapeutics, Inc.

AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001398733

In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Aquestive Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
121
+9 vs. Q4 2024
Shares held
44.3M
+1.11M (+2.6%) vs. Q4 2024
Total value
$127.8M
−$25.8M (−16.8%) vs. Q4 2024
New holders
28
46 more added
Sold out
19
29 more reduced

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AQST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 121 institutions
Q1 2021: 64 institutionsQ2 2021: 60 institutionsQ3 2021: 46 institutionsQ4 2021: 52 institutionsQ1 2022: 51 institutionsQ2 2022: 46 institutionsQ3 2022: 46 institutionsQ4 2022: 37 institutionsQ1 2023: 35 institutionsQ2 2023: 54 institutionsQ3 2023: 48 institutionsQ4 2023: 57 institutionsQ1 2024: 97 institutionsQ2 2024: 98 institutionsQ3 2024: 117 institutionsQ4 2024: 114 institutionsQ1 2025: 121 institutionsQ2 2025: 117 institutionsQ3 2025: 152 institutionsQ4 2025: 179 institutionsQ1 2026: 180 institutionsQ2 2026: 185 institutions
Value heldQ1 2025: $127.8M
Q1 2021: $86.4MQ2 2021: $62.0MQ3 2021: $64.4MQ4 2021: $62.9MQ1 2022: $40.6MQ2 2022: $10.7MQ3 2022: $18.6MQ4 2022: $13.5MQ1 2023: $17.0MQ2 2023: $31.5MQ3 2023: $21.5MQ4 2023: $48.1MQ1 2024: $176.8MQ2 2024: $110.7MQ3 2024: $232.4MQ4 2024: $154.4MQ1 2025: $127.8MQ2 2025: $157.6MQ3 2025: $369.3MQ4 2025: $467.0MQ1 2026: $298.6MQ2 2026: $299.5M
Institutions holding AQST and their total value by quarter
QuarterHoldersValue
Q2 2026185$299.5M
Q1 2026180$298.6M
Q4 2025179$467.0M
Q3 2025152$369.3M
Q2 2025117$157.6M
Q1 2025121$127.8M
Q4 2024114$154.4M
Q3 2024117$232.4M
Q2 202498$110.7M
Q1 202497$176.8M
Q4 202357$48.1M
Q3 202348$21.5M
Q2 202354$31.5M
Q1 202335$17.0M
Q4 202237$13.5M
Q3 202246$18.6M
Q2 202246$10.7M
Q1 202251$40.6M
Q4 202152$62.9M
Q3 202146$64.4M
Q2 202160$62.0M
Q1 202164$86.4M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Aquestive Therapeutics, Inc.; share changes are against Q4 2024.

Institutions holding AQST in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Stifel Financial Corp375,128$1.09M0.00%−23,433−5.9%Reduced
Sio Capital Management, LLC391,629$1.14M0.34%+391,629New
Woodline Partners LP407,661$1.18M0.01%−1,653−0.4%Reduced
Bracebridge Capital, LLC459,216$1.33M0.84%00.0%Unchanged
Citadel Advisors LLC459,550$1.33M0.00%+77,872+20.4%Added
Harvey Capital Management Inc499,570$1.45M0.38%+232,180+86.8%Added
Two Sigma Advisers, LP576,400$1.67M0.00%+560,400+3,502.5%Added
Northern Trust Corp587,828$1.70M0.00%−11,984−2.0%Reduced
Goldman Sachs Group Inc818,849$2.37M0.00%−57,688−6.6%Reduced
Blue Owl Capital Holdings LP920,000$2.67M0.86%+20,000+2.2%Added
Janney Montgomery Scott LLC1,059,760$3.07M0.01%+75,275+7.6%Added
Bank of America Corp1,330,525$3.86M0.00%+640,241+92.8%Added
Pale Fire Capital SE1,335,684$3.87M0.47%+809,928+154.1%Added
State Street Corp1,522,655$4.42M0.00%+18,764+1.2%Added
Morgan Stanley1,527,289$4.43M0.00%+790,400+107.3%Added
Geode Capital Management, LLC1,700,706$4.93M0.00%+46,110+2.8%Added
Perceptive Advisors LLC3,727,208$10.8M0.38%+3,727,208New
Vanguard Group Inc4,073,558$11.8M0.00%−273,196−6.3%Reduced
BlackRock, Inc.5,935,754$17.2M0.00%−62,844−1.0%Reduced
Bratton Capital Management, L.P.9,810,958$28.5M100.00%00.0%Unchanged
Stonepine Capital Management, LLC200,000––+40,000+25.0%Added
VR Adviser, LLC0$00.00%−2,629,786−100.0%Sold out
Franklin Resources Inc0$00.00%−2,134,796−100.0%Sold out
MPM Oncology Impact Management LP0$00.00%−1,611,833−100.0%Sold out
Essex Investment Management Co LLC0$00.00%−623,310−100.0%Sold out
Legato Capital Management LLC0$00.00%−186,424−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−140,889−100.0%Sold out
Renaissance Technologies LLC0$00.00%−95,400−100.0%Sold out
Marshall Wace, LLP0$00.00%−55,695−100.0%Sold out
Diametric Capital, LP0$00.00%−35,295−100.0%Sold out
Jane Street Group, LLC0$00.00%−25,757−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−25,010−100.0%Sold out
Simplex Trading, LLC0$00.00%−16,353−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−12,419−100.0%Sold out
Clear Street Markets LLC0$00.00%−6,666−100.0%Sold out
Caitlin John, LLC0$00.00%−5,900−100.0%Sold out
State of Wyoming0$00.00%−5,229−100.0%Sold out
Richard W. Paul & Associates, LLC0$00.00%−1,602−100.0%Sold out
R Squared Ltd0$00.00%−1,010−100.0%Sold out
IFP Advisors, Inc0$00.00%−10−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed
Global Retirement Partners, LLC––––Not filed